Why Chemours Gets A Double Upgrade From This Analyst
Why Chemours Gets A Double Upgrade From This Analyst
Chemours Co (NYSE:CC) reported in late March its fourth-quarter earnings ahead of expectations.
科慕公司（纽约证券交易所代码：CC）在3月下旬公布的第四季度收益超出预期。
With the company's accounting issue in the rearview mirror, many of its businesses seem to be at or near an inflection point, according to BMO Capital Markets.
根据BMO Capital Markets的数据，随着该公司的会计问题浮出水面，其许多业务似乎正处于或接近转折点。
The Chemours Analyst: John McNulty upgraded the rating for Chemours from Underperform to Outperform, while raising the price target from $19 to $34.
科慕分析师：约翰·麦克纳尔蒂将科慕的评级从表现不佳上调至跑赢大盘，同时将目标股价从19美元上调至34美元。
The Chemours Thesis: The company announced its first-quarter guidance well below expectations and there was limited visibility into its performance in 2024, McNulty said in the upgrade note.
Chemours论点：麦克纳尔蒂在升级说明中表示，该公司公布的第一季度预期远低于预期，其2024年的业绩知名度有限。
Check out other analyst stock ratings.
查看其他分析师股票评级。
Chemours' earnings should improve through 2024 and into the next couple of years, as the company gets past "one-offs," the analyst stated.
这位分析师表示，随着Chemours的过去 “一次性”，到2024年以及未来几年，公司的收益应该会有所改善。
"We expect Chemours to outperform the market as it appears things are at trough/coming off trough right now in all of their segments," he added.
他补充说：“我们预计Chemours的表现将超过市场，因为目前所有细分市场的情况似乎都处于低谷/即将走出低谷。”
"Finally, our time with CEO Dignam confirmed she has a solid plan to drive the company going forward," McNulty further wrote.
麦克纳尔蒂进一步写道：“最后，我们与首席执行官迪格南在一起的时光证实了她有一个推动公司向前发展的坚实计划。”
CC Price Action: Shares of Chemours had risen by 3.22% to $27.92 at the time of publication on Tuesday.
CC价格走势：在周二发布时，科慕的股价上涨了3.22％，至27.92美元。
Photo: Courtesy Chemours
照片：由 Chemours 提供